Physician profile
Christopher T Melroy
NPI 1659399368
$297,948.97
in general payments reported to CMS, 2019-2025
13 companies · $97K in 2025
The $97K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $1,222 · 2021: $16K · 2022: $40K · 2023: $85K · 2024: $59K · 2025: $97K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $208K · Travel and Lodging: $25K · Food and Beverage: $7,060 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $207,600.00 |
| Travel and Lodging | $25,400.92 |
| Food and Beverage | $7,059.50 |
| Education | $101.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $294,392.80 | 2021-2025 | Nucala |
| Aerin Medical INC. | $968.86 | 2019-2023 | |
| Medtronic USA, INC. | $950.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $684.34 | 2021-2025 | Dupixent |
| Integra Lifesciences Corporation | $238.79 | 2019-2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Acclarent, INC | $188.94 | 2019-2022 | |
| Genzyme Corporation | $183.53 | 2020-2025 | |
| Neurent Medical Limited | $166.05 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Sanofi-Aventis U.S. LLC | $67.99 | 2024 | |
| Amgen INC. | $34.00 | 2025 | |
| Olympus America INC. | $27.00 | 2021 | |
| Carestream Dental, LLC | $26.72 | 2021 | |
| Optinose US, INC. | $19.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Melroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.